| Hans-Günter Meyer-Thompson | Hepatitiden
A sofosbuvir-based quadruple regimen is highly effective in HCV type 4-infected Egyptian patients with DAA treatment failure
A sofosbuvir-based quadruple regimen is highly effective in HCV type 4-infected Egyptian patients with DAA treatment failure
Abdel-Moneim, Adel et al.
Journal of Hepatology , Volume 0 , Issue 0 , doi.org/10.1016/j.jhep.2018.03.010
http://www.journal-of-hepatology.eu/article/S0168-8278(18)30174-0/fulltext